SCHEMBL2012583

SCHEMBL2012583

CN(C(=O)c1ccc2[nH]ncc2c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.64
HCRTR2 O43614 2/20 0.64
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
ROCK2 O75116 10/20 0.42
ROCK1 Q13464 9/20 0.42
CDC7 O00311 2/20 0.40
PLK4 O00444 2/20 0.40
AURKA O14965 2/20 0.40
PRKCG P05129 2/20 0.40
CDK1 P06493 2/20 0.40
PRKACA P17612 2/20 0.40
RPS6KB1 P23443 2/20 0.40
CDK2 P24941 2/20 0.40
AKT1 P31749 2/20 0.40
GSK3A P49840 2/20 0.40
GSK3B P49841 2/20 0.40
IRAK1 P51617 2/20 0.40
RPS6KA3 P51812 2/20 0.40
PRKX P51817 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2012515 0.87 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9ACTNNB1
SCHEMBL2010961 0.85 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2012638 0.85 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9AMAOB
SCHEMBL2017845 0.84 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AMAOB
SCHEMBL2014120 0.84 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AMAOB
SCHEMBL2010943 0.84 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AMAPK1
SCHEMBL13139060 0.83 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2011910 0.83 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2013785 0.83 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2013516 0.83 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed